Page 40 - Simulations Plus Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Drug modeling software company Simulations Plus Inc. beat analyst estimates for its second fiscal quarter, with net income increasing a whopping 49 percent. The Lancaster-based company, which makes a platform used by the pharmaceutical industry for drug research and development, reported an adjusted net income of $3.2 million (15 cents a share) for the quarter ended Feb. 28, compared to adjusted net income of $2.15 million (12 cents) for the same quarter a year ago. Revenue increased 27 percent year over year to $13.1 million. Analysts had expected earnings of 14 cents a share on revenue of $...

Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Simulations Plus Inc (NASDAQ: SLP) Popular Searches Operator Greetings and welcome to Simulations Plus Second Quarter Fiscal 2021 Financial Results Conference Call and Webinar. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Jeff Stanlis from H...

Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth...

Here’s Why Conestoga Capital Advisors Sold Proto Labs Inc. (PRLB) Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s Small Cap Growth fund and 19.72% return by its SMid Cap Growth Fund for the the end year 2020. Both performed below their Russell 2000 Growth and Russell 2500 Growth benchmarks that delivered a 34.63% and 25.89% return respectively. You can view the fund’s top 5 ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Simulations Plus Enters Agreement with Distributor in China February 2, 2021 GMT LANCASTER, Calif.--(BUSINESS WIRE)--Feb 2, 2021-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a distribution agreement with Mosim, one of China’s leading biopharmaceutical services companies, to distribute MonolixSuite™, the Lixoft division’s phar...